Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07357428
What this trial is testing

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)

Who this might be right for
Amyotrophic Lateral SclerosisNeuromuscular DiseaseStroke+3 more
Paradromics 2
Testing effectiveness (Phase 2)Ended earlyNCT01384162
What this trial is testing

An Open Label, Safety and Tolerability Continuation Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 15
Not applicableLooking for participantsNCT05067179
What this trial is testing

Analysis of Human ALS Tissues and Registry of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Illinois at Chicago 40
Not applicableStudy completedNCT02306109
What this trial is testing

Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Unita' Sanitaria Locale Di Modena 65
Testing effectiveness (Phase 2)UnknownNCT00753571
What this trial is testing

Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University 40
Early research (Phase 1)Ended earlyNCT02269436
What this trial is testing

A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 11
Testing effectiveness (Phase 2)UnknownNCT04987671
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS

Who this might be right for
ALS
Amylyx Pharmaceuticals Inc. 14
Testing effectiveness (Phase 2)WithdrawnNCT02116634
What this trial is testing

Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Alzahra Hospital, Iran
Testing effectiveness (Phase 2)Study completedNCT03168711
What this trial is testing

Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 48
Not applicableNot Yet RecruitingNCT07170865
What this trial is testing

Dynamic Impact of NIV on Diaphragmatic Ultrasound in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Non Invasive Ventilation (NIV)
University Hospital, Grenoble 20
Not applicableStudy completedNCT03645031
What this trial is testing

Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Neuromuscular Diseases
University of Florida 29
Testing effectiveness (Phase 2)Ended earlyNCT03613571
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of ILB in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
TikoMed AB 13
Testing effectiveness (Phase 2)Study completedNCT03883581
What this trial is testing

Impact of Nuedexta on Bulbar Physiology and Function in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Florida 28
Not applicableStudy completedNCT04468919
What this trial is testing

Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit

Who this might be right for
Amyotrophic Lateral SclerosisBrainstem StrokeMuscular Dystrophies+5 more
Oregon Health and Science University 55
Not applicableStudy completedNCT02236065
What this trial is testing

Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders

Who this might be right for
Brain InjuryCerebral PalsyAmyotrophic Lateral Sclerosis+1 more
MinYoung Kim, M.D. 10
Not applicableStudy completedNCT02447952
What this trial is testing

Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
GlaxoSmithKline 25
Not applicableStudy completedNCT01874808
What this trial is testing

From Movement Preparation to Gait Execution in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut National de la Santé Et de la Recherche Médicale, France 59
Large-scale testing (Phase 3)Study completedNCT01160263
What this trial is testing

Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls

Who this might be right for
Amyotrophic Lateral Sclerosis
Assistance Publique - Hôpitaux de Paris 16
Not applicableStudy completedNCT05019014
What this trial is testing

Olfactory Deficits in Neurologic Disease

Who this might be right for
Alzheimer DiseaseTraumatic Brain InjuryAmyotrophic Lateral Sclerosis+3 more
Massachusetts General Hospital 201
Not applicableAvailableNCT05281484
What this trial is testing

Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Clene Nanomedicine
Next Page